Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.45B 1.11B 993M 918M 836M 1.57B 106B 1.6B 11.05B 4.34B 55.17B 4.18B 4.09B 176B P/E 2026 *
16.5x
P/E 2027 * 13.9x
Enterprise Value 6.21B 929M 828M 765M 697M 1.31B 88.25B 1.33B 9.21B 3.62B 46B 3.49B 3.41B 147B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.32x
Free-Float
51.88%
Yield 2026 *
2.78%
Yield 2027 * 3.8%
1 day+1.49%
1 week+18.11%
Current month+21.08%
1 month+20.97%
3 months+14.66%
6 months+3.84%
Current year+0.93%
1 week 10.95
Extreme 10.95
13.1
1 month 10.58
Extreme 10.58
13.1
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 2023-11-21
President 60 2019-11-24
Director of Finance/CFO 44 2023-11-21
Director TitleAgeSince
Chairman 60 2009-05-31
Chairman 61 2009-05-31
Director/Board Member 44 2016-11-15
Date Insider Type Main position Quantity % Market Cap. Importance
5/12/26 Buy

Founder

1,359,000 0.3397%
5/12/26 Sell

Founder

-2,727,600 0.6818%
5/11/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.49%+18.11%-6.35%-41.48% 1.11B
+2.17%+6.87%-36.53%+3.10% 15.67B
+12.04%-4.19%+7.11%-24.18% 7.07B
+1.47%+3.93%-11.49%+4.70% 6.34B
+0.43%+2.77%-12.18%-2.43% 6.34B
+1.52%+5.07%-49.24%-38.04% 6.19B
-3.17%+4.28%+1.54%-10.77% 4.54B
-1.25%+12.01%-34.35%-2.11% 3.41B
+0.26%+1.03%-14.03%-10.40% 3.24B
-0.69%-0.80%+6.34%-22.43% 3.17B
Average +1.43%+3.91%-14.92%-14.41% 5.71B
Weighted average by Cap. +2.14%+3.89%-19.61%-9.64%

Financials

2026 *2027 *
Net sales 17.57B 2.63B 2.34B 2.16B 1.97B 3.71B 250B 3.77B 26.05B 10.23B 130B 9.86B 9.65B 415B 18.59B 2.78B 2.48B 2.29B 2.08B 3.93B 264B 3.99B 27.55B 10.82B 138B 10.43B 10.21B 439B
Net income 456M 68.23M 60.78M 56.18M 51.15M 96.35M 6.48B 98M 676M 266M 3.38B 256M 251M 10.77B 547M 81.78M 72.85M 67.34M 61.3M 115M 7.76B 117M 811M 318M 4.05B 307M 300M 12.91B
Net Debt -1.24B -185M -165M -153M -139M -262M -17.59B -266M -1.84B -721M -9.17B -695M -681M -29.25B -1.42B -213M -190M -175M -160M -301M -20.22B -306M -2.11B -829M -10.54B -799M -782M -33.61B
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
26-10-16 CN¥12.98 +1.49% 32,459,026
26-10-15 CN¥12.79 +2.65% 34,925,816
26-10-14 CN¥12.46 +5.95% 33,122,819
26-10-13 CN¥11.76 +1.03% 18,755,326
26-10-12 CN¥11.64 +5.91% 19,899,097
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
12.98CNY
Average target price
13.19CNY
Spread / Average Target
+1.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock